STAT+: Generic GLP-1 drugs could help Medicare drive a harder bargain for Ozempic and Wegovy

The advent of the first generic GLP-1 drugs could help Medicare negotiate a lower price for the highly sought after diabetes and obesity medication semaglutide, according to experts familiar with the price-negotiation program and STAT’s review of documents from the first round of negotiations.

Continue to STAT+ to read the full story…